Concepedia

T. Koyama

TK

3

Publications

91

Citations

3

H-Index

2022

Active since

Affiliations

Florida Cancer Specialists & Research Institute(Current)

The University of Texas MD Anderson Cancer Center

Dana-Farber Cancer Institute

Daiichi Sankyo (United States)

Sarah Cannon

T. Koyama is an author at Florida Cancer Specialists & Research Institute specializing in medicine, oncology, and radiation oncology.

Top concepts

Publications per year

2022–2023

3

Publications

3

OA05.05 Ifinatamab Deruxtecan (I-DXd; DS-7300) in Patients with Refractory SCLC: A Subgroup Analysis of a Phase 1/2 Study

Melissa L. Johnson, Mark M. Awad, T. Koyama et al. · Journal of Thoracic Oncology · 2023 · 39 citations · Full text

, , +4

453O DS-7300 (B7-H3 DXd antibody-drug conjugate [ADC]) shows durable antitumor activity in advanced solid tumors: Extended follow-up of a phase I/II study

T. Doi, Minesh Patel, G.S. Falchook et al. · Annals of Oncology · 2022 · 34 citations

, , +7

690P Ifinatamab deruxtecan (I-DXd; DS-7300) in patients with advanced solid tumors: Updated clinical and biomarker results from a phase I/II study

Manish R. Patel, Toshihiko Doi, T. Koyama et al. · Annals of Oncology · 2023 · 18 citations

, , +5

Rows per page

1–3 of 3